openPR Logo
Press release

Global Dermatological Devices Market

06-14-2017 02:53 PM CET | Health & Medicine

Press release from: Medical Device By CMI

The Global Dermatological Devices Market was valued at US$ 6,565.5 million in 2015 and is projected to expand at a CAGR of 7.6% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.Rise in number of patients suffering from non-melanoma and melanoma skin cancers is expected to be one of the major factor to drive the dermatology devices market in the near future. According to WHO, each year around 2 to 3 million non-melanoma and around 132,000 melanoma skin cancers are reported worldwide.
Introduction of histopathology in the field of dermatology has improved the diagnostic process in considerable manner. Skin is an organ that can be easily accessed by the specialist for visual inspection and sample collection for biopsy. There has been a significant demand for in-vivo diagnostic technology, which can be combined along with minimally invasive therapies. Confocal microscopy is gaining traction in the medical diagnostic field, which proves the establishment of dermoscopy. A multidisciplinary approach advancements in physics, chemistry, and molecular biology for diagnosis and treatment of dermatology patients is the need of the hour, which would further complement the techniques currently employed such as pulsed light and photodynamic therapy (PDT). There are various techniques included in the field of dermatology such as multiphoton laser scanning microscopy, which is used to obtain the images from cellular and intracellular level. Raman spectroscopy is another technique that is used to identify the type of lesions on the skin by the help of molecular composition. Multispectral color imaging for dermatological diagnosis of inflammatory and immunologic diseases is a novel application in diagnostic field and this technology has been applied to diagnosis of melanomas.

Request Sample Copy of Research @
www.coherentmarketinsights.com/insight/request-sample/117

Most of the skin diseases are not well known to the society in terms of their frequency, impact, etiology, and prevention. More recently, these are frequent cause of disability and discomfort globally. According to Centers for Disease Control and Prevention paper published in 2004, one in three people in the U.S. suffers from skin condition that leads to at least a one-time visit to a dermatologist. However, there are few variations as such disorders are does not depend on the person’s gender, age, or race. Furthermore, the information from previous surveys suggests reoccurrence and results of such disorders have been modified over the course of time due to environmental factors and other demographic factors. According to the Americans with Disabilities Act of 1990, such complications may be used as a reason for exclusion from employment. Around US$ 300 million per year is the estimated cost associated with dermatological conditions. In the U.S., it has been estimated that occupational skin diseases (OSDs) are the second most frequently occurring dermatological disease. Furthermore, in the past few years, OSDs has contributed to around 15 to 20% of all occupational diseases. Also, dermatitis accounted to around 90 to 95% of all OSDs with approximately 80% on forearm. Contact with irritants and allergens in occupational and non-occupational settings is the main cause for hand dermatitis. Increasing incidence of these conditions creates a highly conduce environment for growth of the global dermatology devices market.

Ask for Discount before buying the Report@
www.coherentmarketinsights.com/insight/request-discount/117

Key take aways of the global dermatology devices market:

The global dermatology devices market is expected to expand at a CAGR of 7.6% during the forecast period (2016–2024). The market is expected to grow at a significant CAGR over the forecast period owing to rise in adoption rate for radiofrequency devices used for cosmetic surgery.
The laser product type segment in the global dermatology devices market was the largest in 2015 and is expected to dominate the market throughout the forecast period in terms of value. Rise in number of application used in healthcare industry for treatment of various abnormalities such as scar, vascular lesions and also skin rejuvenation

In terms of application, the scar removal segment is expected to expand at a significant CAGR of 8.9% during the forecast period. Owing to increased consumer consciousness towards appearance is expected to favor the dermatology devices market. Also, companies are adopting online sales channel to capture greater chunk of the market especially in India and China wherein the market potential is comparatively higher than that in developed countries.
The global dermatology devices market is characterized by rise in advancements and procedures for laser therapy for treating various skin disorders such as removal of external ulcers, warts, skin tumors, along with tattoo removal and treatment of hemangiomas
Some of the major players are Syneron Candela Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Cutera, Lutronics Corporation, Beijing Toplaser Technology Co. Ltd., Alma Lasers, Ltd, Valeant Pharmaceuticals International Inc., Cynosure Inc., Lumenis

Browse Global Strategic Business Report@
www.coherentmarketinsights.com/press-release/dermatologic...

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dermatological Devices Market here

News-ID: 579074 • Views: 155

More Releases from Medical Device By CMI

Custom Procedure Trays and Packs Market – Insights
Increasing number of surgical procedures is fuelling the adoption of custom procedure trays and packs (CPTP) market during the forecast period. For instance, according to the WHO, global volume of the surgeries performed in 2012 was estimated to 266.2 to 359.5 million, out of which one in every 20 operations globally was done in very-low-expenditure Member States. Increase in geriatric population, who are more likely to develop chronic wounds as they
Robotic Rehabilitation and Assistive Technologies Market, By Product Type
Rehabilitation robotics and assistive technologies allow for use of robotic devices for rehabilitation of patients suffering from mobility issues. Robotic rehabilitation and assistive technologies allow for application of robotics in therapeutic procedures to help with recovery a person from various diseases or disabilities such orthopedic traumas, neuromotor disorders, cognitive diseases, strokes and spinal cord injury. Assistive robotics allows people suffering from degenerative motor and/or cognitive abilities to lead an independent
Spectrophotometer Market : Moving Towards a Brighter Future
North America is expected to hold dominant position in the market and is also expected to show significant growth in the spectrometer market, due to increasing launch of novel products in the region by key players. For instance, in February 2018, Thermo Fisher Scientific, a U.S.-based company, launched TSQ 9000 Triple Quadrupole GC-MS/MS System. This system has been designed to increase productivity, with enhanced sensitivity, and it also reduces maintenance
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications Clinical mass spectrometry serves as a quantitative and qualitative analytical tool for assessment of complex mixtures in all the phases of drug development, including identification of the lead compound and their conformational details. Clinical laboratories use automation for the management of large number of samples through, either total automation systems or high level analyzer automation that are offered by clinical mass spectrometers

All 70 Releases


More Releases for Coherent

PHASE-XS – A New Proprietary Database of Coherent Market Insights
PHASE-XS is a database developed by Coherent Market Insights, a market intelligence and consulting company. This database provides clinical information about phase 3 and phase 4 products for biologics and biosimilars. Information related to trial design, current phase, patent expiry, indication, technology, therapeutic category, approved indications, end point analysis, research locations, dosage, physician-administered or self-administered, route of administration, update, reimbursement, addressable patient population, and more of key data is included
Semiconductor Lasers Market: ASML, Axcel Photonics, Coherent, IPG Photonics, New …
MarketResearchReports.Biz announced the analysis report titled "Global Semiconductor Lasers Market": Industry Analysis, Size, Share, Growth, Trends, and Forecasts. The Semiconductor Lasers Market has been comprehensively detailed in the report with special focus on a range of key elements such as market share, forecast and base figures, CAGR, driving factors, growth restraints, and business opportunities. Buyers of the report are expected to be informed about significant improvements in the market and its
New Report By Coherent Market Insights: Zika Vaccines Market
Zika vaccines are developed for immunization & prevention against diseases caused by Zika virus. This virus belongs to genus Flavivirus and is transmitted by Aedes mosquitoes. The virus can also be transmitted through blood transfusion, sexual contact or from infected pregnant women to the fetus. Diagnosis of this infection is confirmed by detecting viral DNA through PCR. However, only 1 in 4 people with zika infection are prone to develop